Objectives: There is a complex relationship between maternal obesity, fetal adiposity and overgrowth that underpins the intergenerational cycle of obesity. The aim of this study is to determine the association between cardiometabolic biomarkers and fetal adiposity and biometry measurements. Methods: Data was derived from the LIMIT interventional trial involving 2212 pregnant women who were overweight or obese at their first antenatal visit. Estimated fetal weight (EFW), biometry and fetal adiposity ultrasound measurements (mid-thigh fat mass, subscapular fat mass, abdominal fat mass) were obtained from 911 women enrolled in the standard care group, measured at 28 and 36 weeks' gestation. Maternal biomarkers including C reactive protein (CRP), triglycerides, fasting glucose, leptin and adiponectin were measured at 28 and 36 weeks. Results: After adjusting for confounders including body mass index (BMI), study centre, parity, maternal age, smoking and socioeconomic status, higher levels of triglycerides were associated with an increase in EFW ( Conclusions: This is the first study to determine the association between cardiometabolic biomarkers, fetal growth and adiposity in overweight and obese women. Higher levels of lipids and lower levels of adiponectin are associated with an increase in fetal growth and adiposity measures on ultrasound. This study contributes to the further understanding of the fetal overgrowth pathway and could be a useful biomarker in the modulation of fetal growth in utero.
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Distal right coronary arterial flow in growth-restricted fetuses: a feasible sign of heart-sparing effect with reserved heart function?
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2,1
1 Obstetrics and Gynecology, Dokkyo Medical University, Shimotsugagun Mibumachi, Tochigi, Japan; 2 Perinatal Medical Centre, Dokkyo Medical University, Mibu, Tochigi, Japan Objectives: We aim to establish clinical efficacy of demonstrated distal right coronary artery (dRCA) on fetal echocardiography in normal and growth-restricted fetuses. Methods: A total of 252 cases (172 of normal growth and 80 growth-restricted fetuses (FGR)) were enrolled. We employed colour or power Doppler imaging to find the flow in dRCA at the one-third of the apex side of the right ventricular wall. Pulsed Doppler examination was added to prove diastolic dominant velocity (cf image). We investigated the demonstration rate, fetal biometry (growth arrest, cardiothoracic area ratio (CTAR), ventricular wall thickening), amniotic fluid index, Doppler examinations (umbilical artery, middle cerebral artery and aortic isthmus), combined cardiac output (CCO), umbilical venous flow volume (UVFV) and perinatal outcomes.
Results: Distal RCA was demonstrated frequently in FGR cases (normal growth 2.3% (4/172), FGR 44% (35/80), P<0.01). Amniotic fluid index was significantly smaller in dRCA demonstrated (dRCA+) group (dRCA-12.0±0.55cm vs. dRCA+ 9.8±0.64cm) (mean±SE) and cardiothoracic area ratio (CTAR) was larger (34.5±0.53% vs. 40.2±0.73%) among FGR cases. Reversed flow in aortic isthmus (22% vs. 57%) and Caesarean delivery due to fetal indications (22% vs. 46%) was frequent significantly in dRCA+ group. We could not prove differences in CCO, UVFV or adverse perinatal outcomes. Conclusions: Demonstrated dRCA in FGR is suggested to indicate chronic blood flow re-distribution to myocardium, which is a feasible sign of 'heart-sparing' and assumed to reserving cardiac functions.
Supporting information can be found in the online version of this abstract OC02.04 Small head circumference at the 2nd trimester anomaly scan following a normal 1st trimester screening: association to chromosomal anomalies and adverse outcome Fetuses with a HC below 5th centile were grouped according to Z-score and compared to fetuses with a normal HC. A small AC was defined by AC Z-score below -2. Verburg reference charts were used. Results: Among 354,544 fetuses, 11,209 (3.2 %) had a HC below 5th centile.
Chromosomal aberrations was found in respectively 5.2%, 1.4%, 1.1%, and 0.7% of fetuses with HC Z-score < -3, -3 to -2.5, -2.5 to -2, and -2 to -1.6 compared to 0.3% in fetuses with normal HC (odds ratio (OR) -2.5 to -2 group vs. normal: 4.41 (CI: 3.12-6.22). CNS malformations was noted in respectively 6.7%, 1.4%, 1.0%, and 0.7% vs. 0.2% in the group with normal HC, OR -2.5 to -2 group vs. normal: 4.67 (CI: 3.27-6.66).
The risk of miscarriage/perinatal death, termination of pregnancy, preterm delivery, and smallness for gestational age was significantly higher in the groups with a HC Z-score below -2 and was inversely correlated to HC.
The outcome was generally worse if AC Z-score was below -2. The risk of adverse outcome increased rapidly when HC Z-score was below -3. Conclusions: A HC Z-score below -2 at the 2nd trimester scan is associated with increased risk of chromosomal aberrations and CNS malformations, warranting expert scan and high-resolution chromosomal microarray analysis. The incidence of adverse outcome is lower than previously reported, which was expected in this population of women with a normal 1st trimester scan/risk assessment.
